How to Conquer Coronavirus: Top 35 Treatments in Development

As the world scrambles to monitor and contain the COVID-19 outbreak, drug companies are racing to develop or repurpose treatments to combat the potential pandemic. The death toll continues to climb. The first U.S....

Improving Integrated Clinical Trial Management Systems through Blockchain

Clinical trials are an expensive stage in a pharmaceutical product’s development. According to a recent study,1 it costs more than $2.6 billion to bring a drug to market. R&D costs play a significant role,...

Anticancer siRNAs Delivered to Cells Using MOF Nanoparticles

Scientists from the University of Cambridge have developed a highly porous type of nanoparticle known as a metal-organic framework (MOF) that can deliver disease gene targeting small interfering RNAs (siRNAs) directly to cells. There...

Hyper-Long Telomeres Give Non-Genetically Modified Mice Longer, Healthier Lives

Scientists at the Spanish National Cancer Research Centre (CNIO) generated the first mice that have super-long telomeres in every one of their body cells. Studies with the animals showed that in comparison with mice...

GENcast: Explore, Learn, and Collaborate on Viral Safety in Biomanufacturing

Ask the average person on the street what they think of after hearing the phrase viral safety, and you will most likely be regaled with stories about scientists in hazmat suits saving Matt Damon...

Potential Diabetes Target Makes Subtle Changes with Big Impact on Metabolic Health

An enzyme that fine-tunes the structure of ceramide lipid molecules could represent a promising new target for metabolic disorders including prediabetes, diabetes, and heart disease, according to a University of Utah Health-led research team....

Invitrocue Leads Market With Personalised Oncology Solutions

Invitrocue Ltd (ASX:IVQ) chief executive officer Steven Fang speaks to Proactive Investors about the oncology-focused company's development of cancer treatments by testing specific drugs on laboratory-controlled micro-tumours. "We've been able to...

Potential Diabetes Target Makes Subtle Changes with Big Impact on Metabolic Health

An enzyme that fine-tunes the structure of ceramide lipid molecules could represent a promising new target for metabolic disorders including prediabetes, diabetes, and heart disease, according to a University of Utah Health-led research team....

Anticancer Immune Cells Identified Using Antigen Receptor Barcode Tracker

Australian scientists have developed a kind of barcode tracking system for cells that can identify rare immune system cells that are produced in response to cancer. The patented Repertoire and Gene Expression by Sequencing...

GENcast: Explore, Learn, and Collaborate as Next-Generation Bioprocessing Moves Toward Future Horizons

/* custom css */ .td_uid_1_5d3d7246c1d42_rand { min-height: 0; } /* custom css */ .td_uid_2_5d3d7246c2001_rand { vertical-align: baseline; } We come upon the scene of a brightly lit bioproduction laboratory with a group of scientists watching their...

Stay connected

47,526FollowersFollow
14,700SubscribersSubscribe

Recent posts

Random article